Skip to content

Studio Wit

Active
Private limited companyfounded 2018active for 8 yearsFrans Beirenslaan 177, 2150 Antwerpen, BelgiumKBO/BCE: BE 0696.871.556
Summary

Studio Wit has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€13,248) and a net result of -€10,651. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 20,614 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Nursing and midwifery
NACE 86940
1 site
Size
€3,784total assets 2025
Equity
-€13,248
Loss
-€10,651
Turnover not published (micro format)
Financial health
52 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
2025 accounts 10 days early1 of 3 deeds summarised
Why 52raises riskCapped at 59: negative equityNegative equity -€13,248Loss of €10,651 (financial year 2025)lowers riskSize: total assets €3,784Sector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2025
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 1% of its sector peers (NACE 86, micro)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 0-11
equity -350.1% of total assets
Liquidity 16+4
short-term debt 450.1% · cash 12.6%
Profitability 0-100
return on assets -281.5%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,126 companies, NACE 86, micro)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024highest value 01-2025: 0.1%▼ -0.2 percentage points vs 12-2024lowest value 02-2025: 0.1%● unchanged vs 01-2025lowest value 03-2025: 0.1%● unchanged vs 02-2025lowest value 04-2025: 0.1%● unchanged vs 03-2025lowest value 05-2025: 0.1%● unchanged vs 04-2025lowest value 06-2025: 0.1%● unchanged vs 05-2025lowest value 07-2025: 0.1%● unchanged vs 06-2025lowest value 08-2025: 0.1%● unchanged vs 07-2025lowest value 09-2025: 0.2%▲ +0.1 percentage points vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.3%▲ +0.1 percentage points vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026
No credit on open account
balance sheet total too small for a liquidity verdict, and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 1% on solvency, 2% on liquidity, 1% on profitability and 0% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €3,784
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Negative equity -€13,248
NBB · annual accounts
raises risk · Loss of €10,651 (financial year 2025)
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
19202122232425
2019 to 2025 · latest year -€13,248
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 21-01-2026, 10 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
10 days early
2024
41 days early
2023
23 days early
2022
1 day early
2021
on the day
2020
on the day
2019
90 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 2 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 21 January (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end27-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Back to profitnet €15,605

Key points

  • Risk: Negative equityfinancial year 2025: debts exceed assets -€13,248 View
  • Caution: Among the weakest 5% on solvencysector median 63.0% · 20,614 companies -350.1% View
  • Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View

By topic

Financials

Financial year
2025
Total assets
€3,784
Loss
-€10,651
Solvency
-350.1%
Total assets▼ 79.0%
Net result
20192025
Go to Financials

Timeline

Events
12
Since
2020
Next accounts
by 31-01-2027
  1. 10-01-2024Reappointment: WOUTERS Bianca Irma Freddy (director)
  2. 08-01-2024Annual accounts filed
  3. 30-01-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Nursing and midwiferyNACE 86940
Founded
29-05-2018
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
17
Who signs
Each director alone
Annual meeting
First Monday of December at 18:00
Purpose
“Alle handelingen te stellen die zowel rechtstreeks als onrechtstreeks verband houden met…” (deed in Dutch)
Go to Articles of association

Key facts about Studio Wit

What is the company number of Studio Wit?
0696.871.556. In Belgium the VAT number is the company number with BE in front: BE 0696.871.556.
Where is Studio Wit based?
The registered office is at Frans Beirenslaan 177, 2150 Antwerpen.Company details
What does Studio Wit do?
According to the KBO register, the main activity is nursing and midwifery (NACE 86940).
What is the legal form of Studio Wit?
Private limited company (BV).
When was Studio Wit founded?
On 29-05-2018.
Is Studio Wit still active?
Yes, Studio Wit is an active enterprise in the KBO register.
What is the turnover of Studio Wit?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Studio Wit profitable?
In financial year 2025, Studio Wit made a loss of €10,651.
Where can I find the annual accounts of Studio Wit?
Studio Wit filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Studio Wit due?
By 31-01-2027, for financial year 2026.Timeline

Companies related to Studio Wit

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.